title: Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease.
abstract: The immune system is exquisitely balanced. It has the ability to effectively respond to and control infections while at the same time preventing inappropriate responses to self and environmental antigens. When this response goes awry, either through a failure to activate the immune response, or failure to terminate it, inflammatory pathology results. Posttranslational modifications (PTMs) such as ubiquitination and phosphorylation help ensure that the delicate balance underlying immune signal transduction is maintained. Ubiquitination and phosphorylation affect localization, activity, stability, and interactions of various components of the immune signal transduction machinery. Moreover, ubiquitination and phosphorylation are tightly linked, with one PTM affecting the other. Therefore, in order to find potential therapies for many immune-related pathologies, it is necessary to understand not only how the immune response is activated by ubiquitination and phosphorylation, but also how it is regulated by these PTMs at different stages of the response. An excellent system to study such activation and regulation is the NOD2 pathway. Dysregulation of NOD2 signaling is involved in the pathogenesis of a variety of inflammatory disorders including Crohn's disease, early onset sarcoidosis, and Blau syndrome. More recently NOD2 has been implicated in the development of autoimmune disease, allergy and asthma. This review will focus on what is currently known about how ubiquitination and phosphorylation regulate NOD2 signaling with particular emphasis on novel in vitro substrates which may serve as potential in vivo therapeutic targets for hyperactive NOD2 states. This article is part of a Special Issue entitled: Ubiquitin Drug Discovery and Diagnostics.
authors.affiliation: Department of Pathology, Case Western Reserve University, USA.
authors.forename: Justine T
authors.initials: JT
authors.lastname: Tigno-Aranjuez
authors.forename: Derek W
authors.initials: DW
authors.lastname: Abbott
mesh_terms: D003424:Crohn Disease / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology*; D020022:Genetic Predisposition to Disease; D006801:Humans; D053473:Nod2 Signaling Adaptor Protein / Q000378:metabolism*; D010766:Phosphorylation; D015398:Signal Transduction; D054875:Ubiquitination
chemical_list: C429018:NOD2 protein, human; D053473:Nod2 Signaling Adaptor Protein